Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1ALX-0081----1件: 64 💬
2ALX0081----1件: 64 💬
3Anfibatide1件: Anfibatide---1件: 64 💬
4ANTI-CD20 antibody----2件: 13, 64 💬
5ANTI-VON willebrand factor nanobody----1件: 64 💬
6ANTI-VON willebrand factor nanobody, caplacizumab----1件: 64 💬
7ANTI-VON willebrand factor nanobody, INN = caplacizumab1件: Caplacizumab1件: Caplacizumab 💬 1件: VWF 💬 8件: Complement and coagulation cascades, Coronavirus disease - COVID-19, ECM-receptor interaction, Focal adhesion, Human papillomavirus infection, Neutrophil extracellular trap formation, PI3K-Akt signaling pathway, Platelet activation 💬1件: 64 💬
8Apadamtase alfa1件: Apadamtase alfa2件: Apadamtase alfa ,
Apadamtase alfa and cinaxadamtase alfa 💬 		1件: ADAMTS13 💬 1件: Platelet activation 💬1件: 64 💬
9Apademtase alfa----1件: 64 💬
10ARC 1779----2件: 64, 288 💬
11ARC1779----2件: 64, 288 💬
12ARC1779 injection----2件: 64, 288 💬
13Aspirin tablet1件: Acetylsalicylic acid1件: Aspirin 💬 2件: PTGS1,
PTGS2 💬 		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 64 💬
14BAX930----1件: 64 💬
15BAX930 - recombinant human adamts131件: Apadamtase alfa2件: Apadamtase alfa ,
Apadamtase alfa and cinaxadamtase alfa 💬 		1件: ADAMTS13 💬 1件: Platelet activation 💬1件: 64 💬
16BAX930 or SHP655----1件: 64 💬
17BAX930 or SHP655 or TAK755----1件: 64 💬
18BCMA-CD19 CAR-T therapy----5件: 49, 51, 53, 56, 64 💬
19BMS-986413----1件: 64 💬
20BMS-986414----1件: 64 💬
21Bortezomib injection1件: Bortezomib1件: Bortezomib 💬 1件: PSMB5 💬 8件: Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬1件: 64 💬
22Cablivi1件: Caplacizumab1件: Caplacizumab 💬 1件: VWF 💬 8件: Complement and coagulation cascades, Coronavirus disease - COVID-19, ECM-receptor interaction, Focal adhesion, Human papillomavirus infection, Neutrophil extracellular trap formation, PI3K-Akt signaling pathway, Platelet activation 💬1件: 64 💬
23Cablivi®----1件: 64 💬
24Caplacizumab1件: Caplacizumab1件: Caplacizumab 💬 1件: VWF 💬 8件: Complement and coagulation cascades, Coronavirus disease - COVID-19, ECM-receptor interaction, Focal adhesion, Human papillomavirus infection, Neutrophil extracellular trap formation, PI3K-Akt signaling pathway, Platelet activation 💬2件: 63, 64 💬
25Corticosteroids----12件: 41, 46, 49, 63, 64, 97, 107, 113, 164, 220, 296, 300 💬
26Cryosupernatant plasma----1件: 64 💬
27Cyclosporine1件: Cyclosporine1件: Cyclosporine 💬 5件: PPP3C,
PPP3C,
PPP3C,
PPP3R,
PPP3R 💬 		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬28件: 11, 28, 40, 41, 42, 45, 46, 49, 50, 53, 56, 60, 61, 62, 63, 64, 65, 97, 107, 162, 164, 222, 226, 228, 283, 284, 285, 302 💬
28Danazol1件: Danazol1件: Danazol 💬 3件: AR,
ESR1,
PGR 💬 		12件: Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Estrogen signaling pathway, Hormone signaling, Oocyte meiosis, Pathways in cancer, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬5件: 60, 63, 64, 65, 285 💬
29Desmopressin1件: Desmopressin2件: Desmopressin ,
Desmopressin acetate 💬 		2件: AVPR2,
F8 💬 		5件: Complement and coagulation cascades, Hormone signaling, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬3件: 64, 75, 288 💬
30Desmopressin acetate1件: Desmopressin2件: Desmopressin ,
Desmopressin acetate 💬 		2件: AVPR2,
F8 💬 		5件: Complement and coagulation cascades, Hormone signaling, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬2件: 64, 288 💬
31Dexamethasone1件: Dexamethasone3件: Dexamethasone ,
Dexamethasone sodium phosphate ,
Dexamethasone phosphate 💬 		1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬22件: 13, 14, 16, 19, 28, 35, 63, 64, 70, 74, 75, 81, 84, 90, 96, 97, 222, 235, 257, 296, 299, 331 💬
32Efgartigimod----6件: 11, 14, 35, 53, 63, 64 💬
33HMED-ides1件: Imlifidase1件: Imlifidase 💬 --2件: 64, 221 💬
34IDEC-C2b8, RO 45-2294----1件: 64 💬
35Ides1件: Imlifidase1件: Imlifidase 💬 --1件: 64 💬
36Mabthera1件: Rituximab1件: Rituximab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬17件: 11, 13, 35, 43, 44, 45, 46, 50, 51, 52, 61, 63, 64, 65, 83, 162, 222 💬
37Methylprednisolone1件: Methylprednisolone2件: Methylprednisolone ,
Methylprednisolone acetate 💬 		1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬45件: 2, 6, 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 85, 86, 93, 96, 97, 127, 162, 164, 222, 224, 271, 283, 284, 285, 296, 300 💬
38Minirin1件: Desmopressin2件: Desmopressin ,
Desmopressin acetate 💬 		2件: AVPR2,
F8 💬 		5件: Complement and coagulation cascades, Hormone signaling, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬2件: 64, 288 💬
39Nanobody directed towards THE human A1 domain OF VON willebrand factor----1件: 64 💬
40Octaplas----1件: 64 💬
41Octaplas infusion----1件: 64 💬
42Octaplas SD----1件: 64 💬
43Octaplas®LG----1件: 64 💬
44Octostim----2件: 64, 288 💬
45OMS721----4件: 64, 66, 109, 222 💬
46OMS721 100 MG/ML injection solution, OMS00620646, OMS620646, MASP-2 antibody----2件: 64, 109 💬
47OMS721 185 MG/ML injection solution, OMS00620646, OMS620646, MASP-2 antibody----2件: 64, 109 💬
48Plasma exchange----7件: 13, 43, 44, 64, 95, 171, 222 💬
49Pooled plasma (human), solvent/detergent treated----1件: 64 💬
50Prednisolone1件: Prednisolone1件: Prednisolone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬38件: 3, 11, 13, 14, 18, 25, 26, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 54, 56, 60, 63, 64, 66, 81, 84, 85, 96, 97, 113, 145, 162, 222, 251, 269, 271, 296, 299, 300 💬
51Prednisone1件: Prednisone1件: Prednisone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬54件: 2, 11, 13, 14, 18, 19, 26, 28, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 60, 61, 63, 64, 65, 66, 79, 81, 84, 85, 86, 90, 93, 95, 96, 97, 113, 145, 162, 164, 205, 222, 224, 228, 251, 269, 283, 285, 288, 299, 300, 303, 307, 331 💬
52Radamts-131件: Apadamtase alfa2件: Apadamtase alfa ,
Apadamtase alfa and cinaxadamtase alfa 💬 		1件: ADAMTS13 💬 1件: Platelet activation 💬1件: 64 💬
53Radamts13----1件: 64 💬
54Recombinant A disintegrin and metalloproteinase thrombospondin TYPE-1 motifs 13----1件: 64 💬
55Recombinant A disintegrin and metalloproteinase with thrombospondin TYPE-1 motifs----1件: 64 💬
56Recombinant A disintegrin and metalloproteinase with thrombospondin TYPE-1 motifs 13----1件: 64 💬
57Recombinant adamts13----1件: 64 💬
58Rituximab1件: Rituximab1件: Rituximab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬52件: 11, 13, 14, 19, 26, 34, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 55, 56, 60, 61, 62, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 162, 172, 220, 222, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 💬
59Romiplostim1件: Romiplostim1件: Romiplostim 💬 1件: TPOR 💬 3件: Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway 💬4件: 60, 63, 64, 65 💬
60SHP655----1件: 64 💬
61Standard plasma----1件: 64 💬
62Sulfate, magnesium1件: Sulfate ion1件: Sulfuric acid 💬 --1件: 64 💬
63TAK-755----1件: 64 💬
64TAK-755 or BAX930 or SHP655----1件: 64 💬
65TAK-755 orbax930 or SHP655----1件: 64 💬
66Uniplas----1件: 64 💬
67Water1件: Water1件: Water 💬 --25件: 2, 5, 6, 13, 17, 19, 22, 46, 51, 53, 56, 57, 63, 64, 66, 67, 85, 96, 97, 206, 226, 230, 274, 278, 299 💬